Nuzenio

Bezisterim

Bezisterim news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results - newswire.comnewswire.com · Sat, 08 Aug 2026 16:00:00 GMT BioVie posts corporate presentation outlining bezisterim, BIV201 clinical programs in neurodegeneration, Long COVID, liver disease - BitgetBitget · Fri, 07 Aug 2026 17:42:44 GMT BioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMT BioVie - Bezisterim Shows Statistically Signi - MoomooMoomoo · Thu, 06 Aug 2026 21:25:33 GMT Bezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMT BioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 13:40:09 GMT BioVie says Phase 2 SUNRISE-PD trial of bezisterim met primary endpoint - TipRanksTipRanks · Thu, 06 Aug 2026 13:36:05 GMT BioVie Announces Positive Phase 2 Parkinson’s Trial Results - TipRanksTipRanks · Thu, 06 Aug 2026 13:13:24 GMT

Timeline

Sat, 08 Aug 2026 16:00:00 GMTNew to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results - newswire.com

Fri, 07 Aug 2026 17:42:44 GMTBioVie posts corporate presentation outlining bezisterim, BIV201 clinical programs in neurodegeneration, Long COVID, liver disease - Bitget

Fri, 07 Aug 2026 10:14:16 GMTBioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials Arena

Thu, 06 Aug 2026 21:25:33 GMTBioVie - Bezisterim Shows Statistically Signi - Moomoo

Thu, 06 Aug 2026 16:12:09 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSci

Thu, 06 Aug 2026 13:40:09 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce Biotech

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

BioVie8 live mentions Parkinson8 live mentions Phase6 live mentions SUNRISE4 live mentions Clinical Trials Arena3 live mentions New2 live mentions The Street Show2 live mentions Broadcasts Tonight2 live mentions PM ET2 live mentions Bloomberg Television2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Bezisterim.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.